美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
0069-0353-30	0069-0353	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE, LIQUID FILLED	ORAL	20240417	N/A	NDA	NDA217439	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.25 mg/1	30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0353-30)
0069-0546-30	0069-0546	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE, LIQUID FILLED	ORAL	20240417	N/A	NDA	NDA217439	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.5 mg/1	30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0546-30)
0069-0655-30	0069-0655	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE, LIQUID FILLED	ORAL	20240417	N/A	NDA	NDA217439	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.75 mg/1	30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0655-30)
0069-0757-30	0069-0757	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE, LIQUID FILLED	ORAL	20240417	N/A	NDA	NDA217439	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	1 mg/1	30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0757-30)
0069-0454-30	0069-0454	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE, LIQUID FILLED	ORAL	20240417	N/A	NDA	NDA217439	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.35 mg/1	30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0454-30)
0069-0252-30	0069-0252	HUMAN PRESCRIPTION DRUG	Talzenna	talazoparib	CAPSULE, LIQUID FILLED	ORAL	20240417	N/A	NDA	NDA217439	Pfizer Laboratories Div Pfizer Inc	TALAZOPARIB TOSYLATE	.1 mg/1	30 CAPSULE, LIQUID FILLED in 1 BOTTLE (0069-0252-30)